368 related articles for article (PubMed ID: 10994404)
1. [Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
Weismüller P; Kattenbeck K; Heinroth KM; Ranke C; Trappe HJ
Dtsch Med Wochenschr; 2000 Aug; 125(33):961-9. PubMed ID: 10994404
[TBL] [Abstract][Full Text] [Related]
2. [Exogenous adenosine as an anti-arrhythmia agent].
Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of adenosine triphosphate in terminating supraventricular tachycardia].
Schläpfer J; Fromer M; Kappenberger L
Schweiz Med Wochenschr; 1993 May; 123(18):941-4. PubMed ID: 8497781
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia.
Gupta A; Naik A; Vora A; Lokhandwala Y
J Assoc Physicians India; 1999 Oct; 47(10):969-72. PubMed ID: 10778689
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
Brandão L; de Sousa J; Barreiros MC; Vagueiro MC; Amram SS
Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086
[TBL] [Abstract][Full Text] [Related]
6. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
Borggrefe M; Breithardt G
Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
[TBL] [Abstract][Full Text] [Related]
7. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
8. [Catheter ablation in supraventricular tachycardia].
Pitschner HF; Neuzner J
Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
[TBL] [Abstract][Full Text] [Related]
9. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration].
Volkmann H; Kühnert H; Dannberg G; Küch N; Büttner A
Z Gesamte Inn Med; 1989 Dec; 44(23):707-11. PubMed ID: 2629366
[TBL] [Abstract][Full Text] [Related]
10. Limited dose-effect relationship of adenosine for detection of atrioventricular nodal duality in patients with supraventricular tachycardias.
Schernthaner C; Pichler M; Strohmer B
Med Princ Pract; 2007; 16(5):339-43. PubMed ID: 17709920
[TBL] [Abstract][Full Text] [Related]
11. [Administration of adenosine for termination of atrioventricular nodal reentry tachycardia: induction of atrial fibrillation with rapid conduction over an accessory pathway and unmasking of concomitant Wolff-Parkinson-White syndrome].
Drescher S; Bosch RF; Mewis C; Kühlkamp V
Z Kardiol; 2000 Jun; 89(6):522-6. PubMed ID: 10929437
[TBL] [Abstract][Full Text] [Related]
12. Adenosine in the treatment of supraventricular tachycardia: 5 years of experience (2002-2006).
Riccardi A; Arboscello E; Ghinatti M; Minuto P; Lerza R
Am J Emerg Med; 2008 Oct; 26(8):879-82. PubMed ID: 18926344
[TBL] [Abstract][Full Text] [Related]
13. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
Kühlkamp V; Mewis C; Mayer F; Seipel L
Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
[TBL] [Abstract][Full Text] [Related]
14. [The pharmacological treatment of supraventricular atrioventricular nodal reentry or accessory pathway reentry tachycardias: the usefulness of transesophageal electrophysiological study in the selection of therapy].
Sarubbi B; Ducceschi V; Esposito R; Briglia N; Manzo G; Mayer MS; Santangelo L; Iacono A
Cardiologia; 1996 Jun; 41(6):543-9. PubMed ID: 8766417
[TBL] [Abstract][Full Text] [Related]
15. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic efficacy and diagnostic potential of adenosine in infants and children].
Pfammatter JP; Paul T; Bachmann D; Weber JW; Stocker FP; Kallfelz HC
Z Kardiol; 1995 Mar; 84(3):243-9. PubMed ID: 7732718
[TBL] [Abstract][Full Text] [Related]
17. Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias.
Sellers TD; Kirchhoffer JB; Modesto TA
Prog Clin Biol Res; 1987; 230():283-99. PubMed ID: 3295883
[TBL] [Abstract][Full Text] [Related]
18. [Use of transesophageal left atrial cardiac pacing for assessment of cordarone effectiveness in patients with atrioventricular tachycardia].
Matiushin GV; Shul'man VA; Balog AI; Golovenkin SE; Bezruk AP; Ivanitskiĭ EA; Smirnova OV
Ter Arkh; 1998; 70(6):47-50. PubMed ID: 9695227
[TBL] [Abstract][Full Text] [Related]
19. [High frequency current catheter ablation in treatment of supraventricular and atrioventricular tachycardia].
Hindricks G; Kottkamp H; Willems S; Chen X; Wichter T; Haverkamp W; Yli-Mäyry S; Breithardt G; Borggrefe M
Z Kardiol; 1995; 84 Suppl 2():103-21. PubMed ID: 7571774
[TBL] [Abstract][Full Text] [Related]
20. [The diagnostic and therapeutic usefulness of adenosine triphosphate in supraventricular tachycardias].
Pulignano G; Patruno N; Urbani P; Critelli G
Cardiologia; 1990 Aug; 35(8):671-7. PubMed ID: 2078847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
